DALLAS, March 19, 2021 – A new study found that patients hospitalized with COVID-19 had a higher risk, compared to patients with infectious diseases such as influenza and sepsis in preclinical studies hand. Those who had an ischemic stroke were more likely to be older, male, black race, or with high blood pressure, Type 2 diabetes or irregular heartbeat (atrial fibrillation) compared with COVID-19 patients. another, according to the late breakout science presented today at the International Stroke Conference of the American Stroke Association 2021. The meeting is being held almost, March 17-19, 2021 and is a major global meeting for researchers and clinicians dedicated to the science of stroke and brain health.
For this analysis, researchers accessed the American Heart Association’s COVID-19 Cardiovascular Disease Index to study stroke risk among patients hospitalized for COVID-19, their demographic characteristics, medical history, and side survival. hospital interior. COVID-19 Table data extracted for this study included more than 20,000 hospitalized patients with COVID-19 across the U.S. between January and November 2020.
“These findings suggest that COVID-19 may increase the risk for stroke, although the exact mechanism for this is not known for sure,” said study lead author Saate S. Shakil, MD , a cartographer at the University of Washington in Seattle. “As the pandemic continues, we discover that coronavirus is not just a respiratory illness, but a viral infection that can affect many organ systems.”
Two hundred and eighty-one individuals (1.4%) in the COVID-19 CVD Table on stroke were confirmed by study imaging during hospitalization. Of these, 148 patients (52.7%) had an ischemic stroke; 7 patients (2.5%) had a transient ischemic attack (TIA); and 127 patients (45.2%) experienced a bloating stroke or an undiagnosed type of stroke.
The COVID-19 patient study also found:
- Those with stroke of any type were more likely to be male (64%) and older (average age 65) than non-stroke patients (average age 61);
- About one-third of non-stroke patients had Type 2 diabetes against about one-third of non-stroke patients, and most had high blood pressure (80%). ‘ischemic stroke patients compared with non-stroke patients (58%);
- 18% of ischemic stroke patients had atrial fibrillation, and 9% of non-stroke patients had atrial fibrillation;
- Patients who had a stroke spent an average of 22 days in hospital, compared with 10 days in hospital for non-stroke patients; and
- In-hospital deaths were more than twice as high among stroke patients (37%) compared with non-stroke patients (16%).
In addition, the risk of stroke varied by race. Black patients made up 27% of the patients in the COVID-19 CVD Registry bath for this analysis; however, 31% of cases of ischemic stroke were among black patients.
“We know that COVID-19 pandemic disease has had a disproportionate impact on color communities, but our research shows that Black Americans may have a higher risk of ischemic stroke after get a virus, too, “Shakil said. “Stroke alone can have a devastating effect and overcoming COVID-19 is often a difficult path for those who survive. Together, they can impose a huge tax on patients who have acquired both conditions.”
Shakil said, “It is more important than ever that we prevent the spread of COVID-19 through public health interventions and widespread vaccination.”
In April 2020, the American Heart Association created the CVID-19 CVD Tablet within weeks of the rapid spread of the global pandemic and to provide sightings to hospitalized patients with the novel coronavirus. The Society’s Get With The Guide’s robust registration infrastructure has enabled rapid data collection, including over 37,000 patient records and over 135,000 laboratory reports, with more than 160 registered registration sites (data such as 2/23/21).
Co-authors are Sophia Emmons-Bell, BA; Christine Rutan, BA; Jason Walchok, BA, NRP; James A. de Lemos, MD; Babak Navi, MD, MS; Alexander E. Merkler, MD, MS; Gregory A. Roth, MD, MPH; and Mitchell SV Elkind, MD, MS, FAHA, FAAN. Publications are available in abstract.
This study was funded by the American Heart Association.
Multimedia is available on the right column of solution connection:
The COVID-19 cardiovascular chart describes differences among patients hospitalized with COVID
Risks of COVID-19: Irregular heartbeat may increase risk, not blood pressure medications
The COVID-19 CVD chart describes differences among patients hospitalized with COVID
American Heart Association (COVID-19) coronavirus resources for the general public
COVID-19 Newsroom American Heart Association
American Heart Association (COVID-19) coronavirus resources for health care professionals
American Heart Association announces COVID-19 patient data record
For more news at the ASA 2021 International Stroke Conference, follow us on Twitter @HeartNews # ISC21.
Reports and conclusions of studies presented at scientific meetings of the American Heart Association are the sole authors of the study and do not necessarily reflect the policy or position of the Society. The Society makes no representations or warranties as to accuracy or reliability. The Society receives funding primarily from individuals; foundations and corporations (including pharmaceuticals, appliance manufacturers and other companies) also donate and fund the Society’s special programs and events. The Society has strict policies to prevent these relationships from influencing the content of science. Revenue from pharmaceutical and biotechnology companies, equipment manufacturers and health insurance providers can be found here, and the Society’s full financial information is available here.
The American Stroke Association (ISC) International Stroke Conference is the world’s premier meeting dedicated to the science and treatment of cerebrovascular disease. ISC 2021 is coming, March 17-19, 2021. This 3-day conference features over 1,200 compelling presentations in 21 disciplines that focus on basic, clinical and translational sciences such as which they grow towards a better understanding of stroke pathophysiology with the goal of further development. effective remedies. Participate in the International Stroke Conference on social media via # ISC21.
About the American Stroke Association
The American Stroke Association is committed to saving people from stroke – the number 2 leading cause of death in the world and the leading cause of major disability. We work with millions of volunteers to fund innovative research, fight for stronger public health policies and provide life-saving tools and information to prevent and treat stroke. The Dallas-based association was officially launched in 1998 as a division of the American Heart Association. To learn more or get involved, call 1-888-4STROKE or visit stro.org. Follow us on Facebook, Twitter.
Disclaimer: AAAS and EurekAlert! they are not responsible for the accuracy of press releases posted to EurekAlert! by sending institutions or for using any information through the EurekAlert system.